News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,221 Results
Type
Article (44268)
Company Profile (311)
Press Release (706623)
Multimedia
Podcasts (128)
Webinars (22)
Section
Business (211177)
Career Advice (2116)
Deals (36815)
Drug Delivery (142)
Drug Development (83562)
Employer Resources (176)
FDA (16926)
Job Trends (15539)
News (357822)
Policy (34151)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2641)
Accelerated approval (47)
Adcomms (28)
Allergies (177)
Alliances (51589)
ALS (215)
Alzheimer's disease (1823)
Antibody-drug conjugate (ADC) (461)
Approvals (17312)
Artificial intelligence (692)
Autoimmune disease (297)
Automation (57)
Bankruptcy (373)
Best Places to Work (11768)
BIOSECURE Act (21)
Biosimilars (228)
Biotechnology (184)
Bladder cancer (195)
Brain cancer (76)
Breast cancer (761)
Cancer (5913)
Cardiovascular disease (486)
Career advice (1802)
Career pathing (43)
CAR-T (336)
CDC (59)
Celiac Disease (3)
Cell therapy (915)
Cervical cancer (47)
Clinical research (72458)
Collaboration (2125)
Company closure (5)
Compensation (1412)
Complete response letters (88)
COVID-19 (2817)
CRISPR (114)
C-suite (1163)
Cystic fibrosis (157)
Data (7973)
Decentralized trials (3)
Denatured (38)
Depression (166)
Dermatology (86)
Diabetes (593)
Diagnostics (7018)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (330)
Drug pricing (219)
Drug shortages (34)
Duchenne muscular dystrophy (287)
Earnings (93858)
Editorial (69)
Employer branding (21)
Employer resources (155)
Events (122516)
Executive appointments (1113)
FDA (20708)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1746)
Gene editing (241)
Generative AI (59)
Gene therapy (745)
GLP-1 (1105)
Government (4876)
Grass and pollen (7)
Guidances (409)
Healthcare (19193)
HIV (79)
Huntington's disease (57)
IgA nephropathy (99)
Immunology and inflammation (302)
Immuno-oncology (95)
Indications (195)
Infectious disease (3156)
Inflammatory bowel disease (224)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (295)
Interviews (330)
IPO (16946)
IRA (57)
Job creations (4074)
Job search strategy (1500)
JPM (65)
Kidney cancer (19)
Labor market (101)
Layoffs (592)
Leadership (41)
Legal (8427)
Liver cancer (101)
Longevity (33)
Lung cancer (773)
Lymphoma (432)
Machine learning (62)
Management (60)
Manufacturing (1080)
MASH (195)
Medical device (14020)
Medtech (14145)
Mergers & acquisitions (21121)
Metabolic disorders (1542)
mRNA (217)
Multiple sclerosis (188)
NASH (18)
Neurodegenerative disease (424)
Neuropsychiatric disorders (109)
Neuroscience (3365)
Neurotech (1)
NextGen: Class of 2026 (6648)
Non-profit (4578)
Now hiring (78)
Obesity (727)
Opinion (314)
Ovarian cancer (222)
Pain (274)
Pancreatic cancer (306)
Parkinson's disease (364)
Partnered (34)
Patents (604)
Patient recruitment (678)
Peanut (65)
People (61652)
Pharmaceutical (84)
Pharmacy benefit managers (34)
Phase 1 (22486)
Phase 2 (31891)
Phase 3 (23862)
Pipeline (8872)
Policy (336)
Postmarket research (2660)
Preclinical (9605)
Press Release (68)
Prostate cancer (306)
Psychedelics (57)
Radiopharmaceuticals (331)
Rare diseases (1115)
Real estate (6322)
Recruiting (72)
Regulatory (26330)
Reports (57)
Research institute (2463)
Resumes & cover letters (362)
Rett syndrome (39)
RNA editing (24)
RSV (88)
Schizophrenia (185)
Series A (294)
Series B (216)
Service/supplier (11)
Sickle cell disease (115)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3790)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (99)
The Weekly (88)
Vaccines (1122)
Venture capital (110)
Weight loss (476)
Women's health (129)
Worklife (20)
Date
Today (170)
Last 7 days (825)
Last 30 days (3667)
Last 365 days (30682)
2026 (12910)
2025 (30677)
2024 (35758)
2023 (40626)
2022 (51797)
2021 (56326)
2020 (54790)
2019 (47398)
2018 (35767)
2017 (33135)
2016 (32661)
2015 (38614)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (806)
Alabama (93)
Alaska (7)
Arizona (355)
Arkansas (16)
Asia (42624)
Australia (6848)
California (13383)
Canada (3798)
China (1386)
Colorado (570)
Connecticut (582)
Delaware (414)
Europe (91780)
Florida (2001)
Georgia (426)
Hawaii (3)
Idaho (62)
Illinois (1071)
India (93)
Indiana (611)
Iowa (23)
Japan (553)
Kansas (133)
Kentucky (50)
Louisiana (43)
Maine (76)
Maryland (1603)
Massachusetts (9593)
Michigan (367)
Minnesota (725)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (144)
New Hampshire (84)
New Jersey (3517)
New Mexico (30)
New York (3508)
North Carolina (1717)
North Dakota (9)
Northern California (6700)
Ohio (401)
Oklahoma (24)
Oregon (46)
Pennsylvania (2697)
Puerto Rico (29)
Rhode Island (50)
South America (1179)
South Carolina (87)
South Dakota (2)
Southern California (5284)
Tennessee (212)
Texas (2136)
United States (47328)
Utah (399)
Vermont (1)
Virginia (338)
Washington D.C. (80)
Washington State (1071)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
751,221 Results for "xeris pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xeris Biopharma Reports First Quarter 2026 Financial Results
May 7, 2026
·
12 min read
Press Releases
Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
·
1 min read
Press Releases
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 5, 2026
·
1 min read
Press Releases
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - April 3, 2026
April 5, 2026
·
1 min read
Press Releases
Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance
March 2, 2026
·
16 min read
Press Releases
Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026
February 17, 2026
·
1 min read
Press Releases
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
January 8, 2026
·
6 min read
Press Releases
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 3, 2025
October 5, 2025
·
1 min read
Press Releases
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
November 7, 2025
·
15 min read
Press Releases
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
December 2, 2025
·
5 min read
1 of 75,123
Next
